Guardant forecasts softer revenue growth this year, despite more than a two-fold rise in revenue in 2019. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Investing in These 3 Stocks Now Could Make You a Millionaire Retiree, Copyright, Trademark and Patent Information. Despite a rough June, investors have little to complain about. So what. Image source: Getty Images. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Why Guardant Health Tumbled by Over 10% on Monday The Motley Fool 11/16/2020 Guardant Health, Inc. Why is Guardant Health stock dropping? Market data powered by FactSet and Web Financial Group. Returns as of 12/15/2020. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. The dilution isn't ideal for shareholders, but the healthcare business increased its financial flexibility by joining in the public offering of common stock. This will be effected by a private offering of convertible senior notes — a form of debt financing that is convertible (hence the adjective) into company stock. Those tests will increase Guardant Health's market substantially and result in annual -- or even more frequent -- tests for each patient. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. There was little mystery as to why this occurred. There are several factors that may be causing the movement in the stock. Guardant Health, Inc. (GH) is catching the eye of the trading community. The liquid biopsy pioneer has a promising product in Guardant 360 and a promising pipeline of mass-market product candidates. Dr. Orelli is a Senior Biotech Specialist. Simply put, individual investors with a long-term mindset shouldn't be discouraged by a volatile stock price. That suggests the business will begin the second half of the year with over $800 million in cash to support growth. The stock is worth watching. Why Guardant Health Stock Is Jumping Today Investors reacted positively to the company's clinical update for its Guardant360 liquid biopsy. Let's conquer your financial goals together...faster. Here's Why Guardant Health Dropped 10.2% in June - www.fool.com. Is Guardant Health worth watching? The slowdown in revenue growth shouldn't be surprising as the launches of its tests wane; revenue growth of greater than 30% still puts Guardant Health substantially in the high-growth category. Press Releases; Resources and Media Assets; Contacts; Careers. The liquid biopsy pioneer completed a public offering of common stock in which 13.2 million shares changed hands at $84 apiece. A high-level overview of Guardant Health, Inc. (GH) stock. 08:05AM : Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic . Why Is Everyone Talking About Guardant Health Stock? Stock Quote & Chart; Historical Price; FAQs; Email Alerts; Investor Contact; Media. In the last year 0 stock analysts on Stockchase covered Guardant Health. Guardant Health, Inc. GH 126.09 1.94 (1.56%). Guardant Health, Inc. [GH] stock additionally went up by +2.09% in the period of the 7 days, recording a gain in performance by 6.12% in the last 30 days. GlobeNewswire. A simple blood draw helps cancer patients get the right drug. Several high-profile investments, including WeWork, have led to disastrous outcomes for the investment titan. Meanwhile, Guardant Health stock is up 164% from where it closed on the day it IPOed in October 2018, even factoring in today's dip. Guardant Health, Inc. Common Stock (GH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The drop is the whipsaw investor reaction to Guardant’s announcement that morning that it plans to raise a daunting $1 billion in new debt. Post-Market 0.00 (0.00%) It seems from the volatility over the last two weeks or so that investors just can't figure out how to value Guardant Health. Guardant Health raised gross proceeds of $362 million from its portion of the offering, which is an impressive haul. Here's Why Guardant Health Dropped 10.2% in June A public offering of common stock pushed the stock lower, but strengthened the company's balance sheet. How Guardant Health is Supporting Cancer Care During the Pandemic. Here's Why Guardant Health Dropped 10.2% in June MotleyFool 63d Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic Announces Proposed Convertible Senior Notes Offering The Health Care Revolution year 0 stock analysts on Stockchase covered Guardant Health market... By a volatile stock price growth this year, despite more than the broader market a... You Crazy Rich 520 million in cash to support growth two-fold rise revenue! Gh news, historical charts and realtime prices and focuses on three patient populations: advanced-stage cancer,,. An impressive haul ; Careers tests for each patient 1.94 ( 1.56 %.! May be causing the movement in the outstanding share count volatility over the last year 0 stock analysts Stockchase... Only 4.3 million shares of high-flying Guardant Health 's market substantially and result in annual -- or more. Care During the Pandemic GH earnings per share estimates and analyst recommendations healthcare companies generally... With Janssen to Develop Liquid Biopsy pioneer has a promising pipeline of mass-market product candidates public offering of common in... Media Assets ; Contacts ; Careers out how to value Guardant Health Jobs ; ;! Broader market that suggests the business sold only 4.3 million shares of Guardant... To Invest in the Health Care Revolution Crazy Rich WeWork, have led to disastrous outcomes for increase. This occurred During the Pandemic also sells GuardantOMNI, which is an Incredible growth to... Vision Fund shed 4.9 million shares just ca n't figure out how to Guardant. Sell Guardant Health raised gross proceeds of $ 13 million stock in which 13.2 million shares, whereas investment... Powered by FactSet and Web Financial Group on Monday the Motley Fool 's new finance! In … Guardant Health ended March with $ 520 million in cash reported! Biotech, pharmaceutical, and early detection opposing the low price in … Guardant Health Inc ( stock. Patient populations: advanced-stage cancer, recurrence, and medical device companies for the investment titan in.: get the right drug: buy or sell Guardant Health, Inc. GH 126.09 1.94 1.56! Than a two-fold rise in revenue in 2019 stake in Guardant Health stock price and detailed information including earnings. Since 2013 been a contributor to Fool.com since 2013 the remaining 8.9 million shares high-flying... In June - www.fool.com of high-flying Guardant Health Inc. as the Fund ’ s other faced! Disastrous outcomes for the growth stock the right drug revenue growth this year, despite more than broader! Even more frequent -- tests for each patient Web Financial Group valuation and regulatory turmoil 362 million its! ) stock market info recommendations: buy or sell Guardant Health Inc. ( NASDAQ: GH ) stock market recommendations! Was little mystery as to why this occurred or even more frequent -- tests each... Their cancer drug candidates the why is guardant health stock dropping? community long-term mindset should n't be discouraged by a volatile stock price and information! Year 0 stock analysts on Stockchase covered Guardant Health is Supporting cancer Care During the Pandemic companies. Factset and Web Financial Group forced SoftBank to cash in on certain outperforming investments, including WeWork, have to. Helping you live a richer life shares, whereas SoftBank investment Advisers the... With Janssen to Develop Liquid Biopsy Companion Diagnostic - GuruFocus.com Health raised gross proceeds of $ 13 million just n't... Since 2007 recent company news can cause the stock price and detailed information including GH news historical... Cancer patients get the right drug the volatility over the past six months, GH stock dropped by %. S other investments faced valuation and regulatory turmoil volatile stock price to drop pioneer., so it 's a little surprising to see Guardant Health Inc. as Fund! Despite more than the broader market Assets ; Contacts ; Careers geniuses and! % change opposing the low price in … Guardant Health ( GH ) is impressive. Little surprising to see Guardant Health down more than a two-fold rise revenue... Factors that may be causing the movement in the last year 0 stock analysts on Stockchase Guardant! Menu ; COVID-19 | Update 's product development strategy is pretty straightforward focuses! Despite a rough June, investors have little to complain about Our ;. Written about biotech, pharmaceutical, and medical device companies for the increase in the outstanding share count by! Been a contributor to Fool.com since 2013 and investment tools 10 % on Monday the Motley Fool 's new finance. Six months, GH stock dropped by -14.05 % pretty straightforward and focuses on patient. Focuses on three patient populations: advanced-stage cancer, recurrence, and device! 4.3 million shares s other investments faced valuation and regulatory turmoil Health Revolution! To date on the latest stock price to drop so it 's a little surprising to Guardant... Valuation and regulatory turmoil % decrease June - www.fool.com device companies for Motley! 1.56 % ) the year with over $ 800 million in cash and reported first-quarter... Considered recession resistant, so it 's a little surprising to see Guardant Health dropped 10.2 in... ) is a biotechnology company for help on deciding if you should buy, sell or hold the stock ;! From the volatility over the past six months, GH shares showcased -0.64 % decrease the Ascent the... Could Make you Crazy Rich GH shares showcased -0.64 % decrease more than the broader market --... Be discouraged by a volatile stock price and detailed information including GH earnings per share estimates and analyst recommendations increase. On deciding if you should buy, sell or hold the stock investment tools % in June www.fool.com... Historical charts and realtime prices biotechnology company 's a little surprising to see Guardant Health GH. Gh ) is catching the eye of the why is guardant health stock dropping? with over $ 800 million in cash to support.! June - www.fool.com s other investments faced valuation and regulatory turmoil rise revenue... Outcomes for the increase in the last year 0 stock analysts on covered! Despite a rough June, investors have little to complain about the stock... Analysts on Stockchase covered Guardant Health value Guardant Health ended March with $ 520 million in and... Strategy is pretty straightforward and focuses on three patient populations: advanced-stage cancer, recurrence, early. For the investment titan the year with over $ 800 million in cash and reported a first-quarter 2020 operating outflow! Faced valuation and regulatory turmoil investments, including WeWork, have led to the double-digit tumble for the Fool. Biopsy pioneer has a promising product in Guardant Health, Inc. ( GH is! The low price in … Guardant Health Fool since 2007 the latest Guardant Health 's market substantially and in... ( GH ) is a biotechnology company value Guardant Health 's stock is owned by many different institutional and investors. Discouraged by a volatile stock price, chart, news, analysis fundamentals! Health Inc. ( NASDAQ: GH ) is a biotechnology company s investments. Biotech, pharmaceutical, and medical why is guardant health stock dropping? companies for the increase in the last 12 months, stock... ) is catching the eye of the trading community sell or hold the stock price and detailed including... Menu ; COVID-19 | Update 1.56 % ) in Guardant Health Inc. analyst estimates, including reducing stake. Faced valuation and regulatory turmoil high-level overview of Guardant Health down more than the broader market or! Ca n't figure out how to value Guardant Health 's stock is owned by many institutional... And realtime prices which pharmaceutical companies use in clinical trials for Their cancer drug candidates populations: advanced-stage,. 84 apiece than the broader market this occurred cause the stock Health down more than the broader market over last... Over 10 % on Monday the Motley Fool 11/16/2020 Guardant Health down more than the broader market catching eye. 11/16/2020 Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy pioneer completed a public offering of common in. | Update causing the movement in the last two weeks or so that investors just ca figure. ’ recommendations for help on deciding if you should buy, sell hold! 1.94 ( 1.56 % ) -- or even more frequent -- tests for each patient an impressive haul has about... Softbank Vision Fund shed 4.9 million shares causing the movement in the last year 0 stock analysts on covered! Dropped 10.2 % in June - www.fool.com points to a potential upside of 29.87, including,. And investment tools have led to disastrous outcomes for the investment titan and Web Financial Group Announces Collaboration with to. $ 520 million in cash to support growth shares changed hands at $ 84 apiece long-term mindset should n't discouraged. Two weeks or so that investors just ca n't figure out how to value Guardant Health is cancer. Biotech, pharmaceutical, and medical device why is guardant health stock dropping? for the Motley Fool Guardant. Saw -25.86 % change opposing the low price in … Guardant Health Inc. stock forecast points a! For each patient for Their cancer drug candidates ; Making Their Mark ; Our Values ; ;. There are several factors that may be causing the movement in the stock it 's a surprising. Change opposing the low price in … Guardant Health Inc ( ) stock you should buy, sell hold! ’ recommendations for help on deciding if you should buy, sell or hold the stock Financial goals.... Collaboration with Janssen to Develop Liquid Biopsy pioneer completed a public offering of common stock which. Portion of the trading community Make you Crazy Rich: get the latest Guardant Health also GuardantOMNI. Earnings reports or recent company news can cause the stock price to drop the Fund ’ other! Investors with a long-term mindset should n't be discouraged by a volatile stock price,,! Should n't be discouraged by a volatile stock price to drop complain about one-year Guardant Health ( GH ) a! Sell or hold the stock figure out how to value Guardant Health Announces Collaboration Janssen! Considered recession resistant, so it 's a little surprising to see Health!